Omada Health, Inc. (OMDA) vs SOPHiA GENETICS SA (SOPH)
Omada Health, Inc. and SOPHiA GENETICS SA are both Health Information Services companies. Omada Health, Inc. is the larger, with a market value of $1.2B against $703.2M — 1.7× the size. SOPHiA GENETICS SA has negative trailing earnings, so its P/E is not meaningful; Omada Health, Inc. trades at 281×. Omada Health, Inc. grew revenue faster over the last twelve months: 52.5% against 23.7%. Omada Health, Inc. has the higher net margin (1.39% vs −93.9%) and the higher return on invested capital (−0.93% vs −196.5%). Across the 17 metrics below, Omada Health, Inc. leads on 16 and SOPHiA GENETICS SA on 1.
Valuation
Profitability
| Metric | OMDA | SOPH | Health Information Services median |
|---|---|---|---|
| Gross margin | 68.19% | 66.63% | 63.38% |
| Operating margin | (0.15%) | (85.55%) | (8.35%) |
| Net margin | 1.39% | (93.86%) | (14.70%) |
| Free cash flow margin | 5.53% | (47.83%) | 0.58% |
| Return on equity | 1.84% | (101.22%) | (6.82%) |
| Return on assets | 1.36% | (43.02%) | (6.02%) |
| Return on invested capital | (0.93%) | (196.45%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack